SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-057020
Filing Date
2010-03-15
Accepted
2010-03-15 16:05:57
Documents
13
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1002347
2 COLLABORATION AGREEMENT dex1015.htm EX-10.15 560619
3 OFFICE LEASE AGREEMENT dex1016.htm EX-10.16 394539
4 COMPENSATION INFORMATION FOR NON-EMPLOYEE DIRECTORS dex1017.htm EX-10.17 6669
5 SUBSIDIARIES OF MEDIVATION, INC. dex211.htm EX-21.1 1830
6 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1436
7 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) dex311.htm EX-31.1 6413
8 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) dex312.htm EX-31.2 6429
9 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER dex321.htm EX-32.1 4384
10 GRAPHIC g61660g04q40.jpg GRAPHIC 8544
11 GRAPHIC g61660g12g04.jpg GRAPHIC 38597
12 GRAPHIC g61660g49x68.jpg GRAPHIC 130369
13 GRAPHIC g61660g68u07.jpg GRAPHIC 11296
  Complete submission text file 0001193125-10-057020.txt   2246900
Mailing Address 201 SPEAR STREET, 3RD FLOOR SAN FRANCISCO CA 94105
Business Address 201 SPEAR STREET, 3RD FLOOR SAN FRANCISCO CA 94105 415-543-3470
MEDIVATION, INC. (Filer) CIK: 0001011835 (see all company filings)

IRS No.: 133863260 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32836 | Film No.: 10681567
SIC: 2834 Pharmaceutical Preparations